Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Syndax PharmaceuticalsKura OncologyCara TherapeuticsEagle PharmaceuticalsKadmon
SymbolNASDAQ:SNDXNASDAQ:KURANASDAQ:CARANASDAQ:EGRXNYSE:KDMN
Price Information
Current Price$16.85$17.77$16.07$53.41$4.58
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.71.61.51.02.1
Analysis Score4.44.53.51.33.5
Community Score2.52.63.22.92.6
Dividend Score0.00.00.00.00.0
Ownership Score1.01.01.01.04.0
Earnings & Valuation Score0.60.00.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$22.13$25.00$34.83$52.50$12.00
% Upside from Price Target31.31% upside40.69% upside116.76% upside-1.70% downside162.01% upside
Trade Information
Market Cap$577.52 million$788.84 million$763.31 million$726.27 million$728.14 million
Beta1.932.281.871.021.48
Average Volume605,591516,826557,668171,7412,177,906
Sales & Book Value
Annual Revenue$1.52 millionN/A$19.89 million$195.89 million$5.09 million
Price / Sales400.13N/A37.813.73143.99
CashflowN/AN/AN/A$1.81 per shareN/A
Price / CashN/AN/AN/A29.44N/A
Book Value$1.48 per share$4.47 per share$3.43 per share$13.29 per share$0.60 per share
Price / Book11.39N/A4.694.027.63
Profitability
Net Income$-56,050,000.00$-63,140,000.00$-106,370,000.00$14.31 million$-61,370,000.00
EPS($1.84)($1.51)($2.49)$1.38($0.74)
Trailing P/E RatioN/AN/AN/A314.19N/A
Forward P/E RatioN/AN/AN/A116.1113.88
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-4,013.65%N/A-480.29%1.29%-813.33%
Return on Equity (ROE)-132.06%-30.33%-68.83%8.11%-142.79%
Return on Assets (ROA)-73.26%-27.68%-53.81%5.07%-66.34%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.38%0.03%0.02%0.17%0.20%
Current Ratio5.55%15.19%4.07%1.89%6.42%
Quick Ratio5.55%15.19%4.07%1.83%6.40%
Ownership Information
Institutional Ownership Percentage57.53%87.35%68.86%96.02%85.64%
Insider Ownership Percentage9.50%7.20%5.80%31.70%2.95%
Miscellaneous
Employees38435596116
Shares Outstanding36.10 million45.44 million46.80 million13.69 million160.03 million
Next Earnings Date8/5/2020 (Estimated)8/6/2020 (Estimated)8/5/2020 (Estimated)8/13/2020 (Estimated)8/3/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.